Asset Management

SP Industries, Inc. (SP), a leading designer and manufacturer of state-of-the-art laboratory equipment, biological drug manufacturing solutions, and specialty glassware, has announced that it has acquired privately held Bel-Art Products (Bel-Art). Headquartered in Wayne (NJ, USA), Bel-Art is a global provider of innovative laboratory solutions serving the scientific, industrial, and healthcare end markets.

Much has been written about the business benefits of outsourcing “noncore” activities, and this approach is now well-established in most chemical, pharmaceutical, and biotech companies. By concentrating on core areas and working with specialists for other tasks, costs are better managed, efficiency is boosted, and ROI (return on investment) is increased.

Thanks to cuts to research funding, the DIY movement continues to be a growing trend in laboratories across the U.S., according to a recent article in the Star Tribune.

A bill to be heard today (Feb. 10) before the Wisconsin state Assembly's education committee would keep scientific research from the public eye if it passes.

According to a recent article by Jeff John Roberts of Gigaom, a 1997 patent held by Boston University (BU) could actually be detrimental to public research.

Johns Hopkins University led U.S. universities in research spending for the 34th straight year in fiscal 2012, performing $2.106 billion in medical, science, and engineering R&D, the National Science Foundation says.

“The prudence exhibited by women directors in negotiating mergers and acquisitions has had a substantial positive effect on maintaining firm value,” says Kai Li of the University of British Columbia’s Sauder School of Business.












